After a slow start for the week, the S&P 500 gained 0.6% while the Nasdaq Composite gained 1.4% and the Dow Jones increased by .3%. As you would expect, quarterly earnings were a big factor in driving the markets this week - more results will be released in coming weeks with 75% of S&P 500 members still due to report their earnings. Thus far, this earnings season has delivered some good surprises.
One company with a great earnings report was Johnson & Johnson (JNJ). The company beat both revenue and earnings estimates for the quarter, helping the momentum in U.S. stocks and the healthcare industry. For the quarter, their revenue was $18.48 billion, beating analysts average estimate by $500 million. Earnings for the second quarter were $1.74, 6 cents more than the analysts predicted.
With their great earnings report, ETFs that have a exposure to Johnson and Johnson also lead the way this week. The 2 ETFs that have the biggest exposure to Johnson & Johnson, XLV, Health Care Select Sector SPDR Fund, and CURE, Direxion Daily HealthCare, gained 2% and 4% respectively this week.
Global equities seemed to also do surprisingly well this week despite so many international issues and turbulence including the attempted coup in Turkey, the potential for change in monetary policy from the Bank of Japan next week and the European Central Bank keeping all of its interest rates unchanged on Thursday, adding that it expects rates to remain at present or lower levels for an extended period.
In ETF news, SEC moved to expedite the approval of exchange-traded funds run by human stock and bond pickers. This could lead to even larger and faster growth of the already growing ETF industry. The SEC on Friday approved guidelines for actively managed ETFs, which aim to cut months off the process of bringing these funds to market.
This week BWV, HOMX, PGX, and DIVC were are top 4 of biggest gains in our Quant movers section. Each fund’s quant score increased by 16%, 12%, 12%, and 10% respectively. Our biggest losers this week were IEV, BDCS, MLPG, MLPI. Each fund lost 12%, 10%, 10%, and 9% respectively.
This week was another steady week for our select list. However, there was 1 unranked funds from last week that made it to the top spot in their category, and a number 5 ranked fund that made it to number 1. They were EWU in the European region, and XES, in the energy sector.
Thank you for reading ETF Global Perspectives!
ETFG 21 Day Free Trial: https://www.etfg.com/signup/quick
Assumptions, opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. ETF Global LLC (“ETFG”) and its affiliates and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively ETFG Parties) do not guarantee the accuracy, completeness, adequacy or timeliness of any information, including ratings and rankings and are not responsible for errors and omissions or for the results obtained from the use of such information and ETFG Parties shall have no liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of such information. ETFG PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall ETFG Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the information contained in this document even if advised of the possibility of such damages.
ETFG ratings and rankings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities or to make any investment decisions. ETFG ratings and rankings should not be relied on when making any investment or other business decision. ETFG’s opinions and analyses do not address the suitability of any security. ETFG does not act as a fiduciary or an investment advisor. While ETFG has obtained information from sources they believe to be reliable, ETFG does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or strategies mentioned herein may not be suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue. Prices, values, or income from any securities or investments mentioned in this report may fall against the interests of the investor and the investor may get back less than the amount invested. Where an investment is described as being likely to yield income, please note that the amount of income that the investor will receive from such an investment may fluctuate. Where an investment or security is denominated in a different currency to the investor's currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income of or from that investment to the investor.